COVID-19 and tuberculosis: the double whammy of respiratory pathogens.

Shariq, Mohd; Sheikh, Javaid A; Quadir, Neha; Sharma, Neha; Hasnain, Seyed E; Ehtesham, Nasreen Z

Shariq, Mohd; Sheikh, Javaid A; Quadir, Neha; Sharma, Neha; Hasnain, Seyed E; Ehtesham, Nasreen Z.

Afiliação

Shariq M; ICMR-National Institute of Pathology, New Delhi, India.
Sheikh JA; These authors contributed equally to this work.
Quadir N; Dept of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India.
Sharma N; These authors contributed equally to this work.
Hasnain SE; ICMR-National Institute of Pathology, New Delhi, India.
Ehtesham NZ; Jamia Hamdard-Institute of Molecular Medicine, New Delhi, India.

Eur Respir Rev ; 31(164)2022 Jun 30.

Article em En | MEDLINE | ID: mdl-35418488

Assuntos

COVID-19; Tuberculose; Antituberculosos; Humanos; Pandemias; SARS-CoV-2; Tuberculose/diagnóstico; Tuberculose/tratamento farmacológico; Tuberculose/epidemiologia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Eur Respir Rev Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google